A-1331852 Chemical Structure
Price of A-1331852
We offer a substantial discount on larger orders,
please inquire via email@example.com or Fax: 1-201-884-1288 (USA Fax#)
A-1331852 is a potent and BCL-XL-selective inhibitor. BCL-XL is the major antiapoptotic survival protein and may be a novel therapeutic target in CML. BCL-XL-selective inhibitors have the potential to enhance the efficacy of docetaxel in solid tumors and avoid the exacerbation of neutropenia observed with navitoclax. A-1331852 may have potential as improved cancer therapeutics.
>99 % by HPLC
Room temperature for short term or -20ºC for 3 years.